Induction versus adjuvant chemotherapy combined with concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: a retrospective cohort study

医学 内科学 鼻咽癌 肿瘤科 危险系数 放化疗 诱导化疗 比例危险模型 单变量分析 多元分析 化疗 放射治疗 置信区间
作者
Xiaoli Mu,Hongyan Liu,Juan Wu,Shi Chen,Xingchen Peng,Jing Wang,Zhigong Wei,Ling He,Ji-Yan Liu,Zejun Lu,Yonglin Su
出处
期刊:Aging [Impact Journals, LLC]
卷期号:14 (16): 6727-6739
标识
DOI:10.18632/aging.204246
摘要

Background: Currently available evidence favors the combination of chemotherapy with concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma (LANPC). However, the optimal timing for additional chemotherapy is unclear. This study was conducted to compare the efficacy and toxicity of induction chemotherapy plus concurrent chemoradiotherapy (IC+CCRT) versus concurrent chemoradiotherapy plus adjuvant chemotherapy (CCRT+AC). Methods: Two medical centers in China enrolled patients with LANPC (stage III-IVB) between January 2009 and May 2020. Through the use of propensity score matching (PSM), baseline characteristics were balanced. The primary endpoint was overall survival (OS), which was evaluated by the Kaplan-Meier method and log-rank test. Potential independent prognostic factors were identified using univariate and multivariate Cox proportional hazard analyses. Based on the chi-squared test, we compared the adverse events associated with treatment between the groups. Results: After the implementation of PSM, 159 patients treated with IC+CCRT and 72 patients treated with CCRT+AC were eventually enrolled in this study. There was no significant difference between patients treated with IC+CCRT and CCRT+AC in terms of 3-year OS (94.7% versus 90.9%, p=0.816), progression-free survival (PFS) (91.2% versus 83.1%, p=0.588), locoregional recurrence-free survival (LRFS) (92.5% versus 81.8%, p=0.478), or distant metastasis-free survival (DMFS) (93.4% versus 88.2%, p=0.783). There was no prognostic significance of the treatment for OS, PFS, LRFS, or DMFS (all p > 0.05) in the univariate and multivariate analyses. Patients treated with CCRT+AC had a higher incidence of grade 3 to 4 leucopenia (p=0.001) and neutropenia (p=0.001) than those treated with IC+CCRT. Conclusions: IC plus CCRT achieved comparable survival outcomes to CCRT plus AC and had a lower incidence of toxicity.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
睡到自然醒完成签到 ,获得积分10
1秒前
1秒前
1秒前
1秒前
Musen完成签到,获得积分10
1秒前
科研通AI5应助叫滚滚采纳,获得10
1秒前
1秒前
123456发布了新的文献求助10
1秒前
大方安白发布了新的文献求助10
2秒前
Hello应助正直冰露采纳,获得10
2秒前
lyy完成签到 ,获得积分10
3秒前
沈随便发布了新的文献求助10
3秒前
3秒前
3秒前
4秒前
灵巧荆发布了新的文献求助10
4秒前
丘奇发布了新的文献求助10
4秒前
4秒前
4秒前
通~发布了新的文献求助10
5秒前
5秒前
搜集达人应助FloppyWow采纳,获得10
5秒前
Musen发布了新的文献求助10
5秒前
pluto应助金宝采纳,获得10
6秒前
ii完成签到 ,获得积分10
6秒前
温言发布了新的文献求助10
6秒前
CodeCraft应助务实盼海采纳,获得10
7秒前
orixero应助JUSTs0so采纳,获得10
7秒前
8秒前
欣欣子完成签到 ,获得积分10
8秒前
顺利毕业发布了新的文献求助10
8秒前
西奥完成签到 ,获得积分10
8秒前
9秒前
春分夏至完成签到,获得积分10
9秒前
9秒前
远山完成签到 ,获得积分10
9秒前
9秒前
胖虎应助jiejie采纳,获得20
10秒前
HaoHao04完成签到 ,获得积分10
10秒前
Joshua发布了新的文献求助10
10秒前
高分求助中
Continuum Thermodynamics and Material Modelling 3000
Production Logging: Theoretical and Interpretive Elements 2700
Social media impact on athlete mental health: #RealityCheck 1020
Ensartinib (Ensacove) for Non-Small Cell Lung Cancer 1000
Unseen Mendieta: The Unpublished Works of Ana Mendieta 1000
Bacterial collagenases and their clinical applications 800
El viaje de una vida: Memorias de María Lecea 800
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 基因 遗传学 物理化学 催化作用 量子力学 光电子学 冶金
热门帖子
关注 科研通微信公众号,转发送积分 3527742
求助须知:如何正确求助?哪些是违规求助? 3107867
关于积分的说明 9286956
捐赠科研通 2805612
什么是DOI,文献DOI怎么找? 1540026
邀请新用户注册赠送积分活动 716884
科研通“疑难数据库(出版商)”最低求助积分说明 709762